[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results in 2021

CEO Severin Schwan on the full-year results: “We achieved good results in 2021. The demand for our new medicines and diagnostics remains very high. I am particularly pleased with the progress of our product pipeline across several areas, including oncology, vision loss and neurological diseases. Based on our strong product portfolio in both divisions and the promising product pipeline, we are well positioned for future growth.”
Source: Roche Media News - Category: Pharmaceuticals Source Type: news